A001067 Stock Overview
Manufactures and sells medicines and medical supplies in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
JW Pharmaceutical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩56,100.00 |
| 52 Week High | ₩64,803.92 |
| 52 Week Low | ₩56,000.00 |
| Beta | 0.56 |
| 1 Month Change | -4.43% |
| 3 Month Change | -7.88% |
| 1 Year Change | -7.71% |
| 3 Year Change | -20.02% |
| 5 Year Change | 46.71% |
| Change since IPO | 212.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| A001067 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -3.9% | -2.3% | 2.4% |
| 1Y | -7.7% | 7.4% | 4.4% |
Return vs Industry: A001067 underperformed the KR Pharmaceuticals industry which returned 7.4% over the past year.
Return vs Market: A001067 underperformed the KR Market which returned 4.4% over the past year.
Price Volatility
| A001067 volatility | |
|---|---|
| A001067 Average Weekly Movement | 1.6% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.2% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A001067 has not had significant price volatility in the past 3 months.
Volatility Over Time: A001067's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 1,197 | Young-Sub Shin | www.jw-pharma.co.kr |
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.
JW Pharmaceutical Corporation Fundamentals Summary
| A001067 fundamental statistics | |
|---|---|
| Market cap | ₩665.01b |
| Earnings (TTM) | ₩40.77b |
| Revenue (TTM) | ₩755.74b |
16.3x
P/E Ratio0.9x
P/S RatioIs A001067 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A001067 income statement (TTM) | |
|---|---|
| Revenue | ₩755.74b |
| Cost of Revenue | ₩412.92b |
| Gross Profit | ₩342.82b |
| Other Expenses | ₩302.05b |
| Earnings | ₩40.77b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.75k |
| Gross Margin | 45.36% |
| Net Profit Margin | 5.40% |
| Debt/Equity Ratio | 45.1% |
How did A001067 perform over the long term?
See historical performance and comparison